RegeneRx Biopharmaceuticals, Inc. (RGRX)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 76.76 Thousand | 76.76 Thousand | 76.76 Thousand | 76.76 Thousand | 69.66 Thousand | 56.65 Thousand |
| Cost of Revenue | - | 6.64 | 4.92 | 65.11 | 81.04 | 3048.00 |
| Gross Profit | 76.76 Thousand | 76.75 Thousand | 76.75 Thousand | 76.69 Thousand | 69.58 Thousand | 53.6 Thousand |
| Operating Expenses | 1.47 Million | 1.4 Million | 1.37 Million | 1.33 Million | 1.39 Million | 1.5 Million |
| Selling, General and Administrative Expenses | 1.47 Million | 1.39 Million | 1.36 Million | 1.27 Million | 1.31 Million | 1.35 Million |
| Research and Development Expenses | - | 6638.00 | 4921.00 | 65.1 Thousand | 81.04 Thousand | 143.91 Thousand |
| Other Expenses | - | - | - | - | -582.9 Thousand | - |
| Cost and Expenses | 1.47 Million | 1.4 Million | 1.37 Million | 1.33 Million | 1.39 Million | 1.5 Million |
| Operating Income | -1.4 Million | -1.32 Million | -1.29 Million | -1.26 Million | -1.32 Million | -1.44 Million |
| Interest Expense | 325.64 Thousand | 324.87 Thousand | 232.63 Thousand | 153.41 Thousand | 87.28 Thousand | 170.88 Thousand |
| Income Tax Expense | - | 324.64 Thousand | 228.82 Thousand | 153.41 Thousand | -582.9 Thousand | 98.6 Thousand |
| Earnings before Tax | -1.72 Million | -1.59 Million | -1.52 Million | -1.4 Million | -1.99 Million | 385.09 Thousand |
| Net Income | -1.72 Million | -1.92 Million | -1.75 Million | -1.55 Million | -1.99 Million | 286.48 Thousand |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
| Earnings Per Share Diluted | -1.20 | -0.01 | -0.01 | -0.01 | -0.02 | 0.00 |
| Weighted Average Shares Outstanding | 143.54 Million | 138.59 Million | 133.35 Million | 130.97 Million | 120.71 Million | 107.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 1.43 Million | 138.59 Million | 133.35 Million | 130.97 Million | 120.71 Million | 120.92 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.95 |
| EBIT Margin | -18.26 | -17.30 | -16.82 | -16.28 | -27.32 | -25.45 |
| Profit Margin | -22.50 | -25.04 | -22.83 | -20.29 | -28.62 | 5.06 |
| EBITDA | -1.4 Million | -1.27 Million | -1.29 Million | -1.24 Million | -1.9 Million | -1.44 Million |
| Earnings Before Tax Margin | -18.26 | -17.31 | -16.86 | -16.44 | -19.00 | -25.50 |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 19.19 Thousand | 19.19 Thousand | 76.76 Thousand | 19.19 Thousand |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | 19.19 Thousand | 19.19 Thousand | 76.76 Thousand | 19.19 Thousand |
| Operating Expenses | - | - | 324.1 Thousand | 328.03 Thousand | 1.47 Million | 303.65 Thousand |
| Selling, General and Administrative Expenses | - | - | 324.1 Thousand | 328.03 Thousand | - | 303.65 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | 324.1 Thousand | 328.03 Thousand | 1.47 Million | 303.65 Thousand |
| Operating Income | - | - | -304.91 Thousand | -308.84 Thousand | -1.4 Million | -284.46 Thousand |
| Interest Expense | - | - | 80.29 Thousand | 82.08 Thousand | 325.64 Thousand | 82.08 Thousand |
| Income Tax Expense | - | - | 160.58 Thousand | -21.00 | -183.00 | -37.00 |
| Earnings before Tax | - | - | -385.2 Thousand | -390.9 Thousand | -1.72 Million | -366.5 Thousand |
| Net Income | - | - | -545.78 Thousand | -390.88 Thousand | -1.72 Million | -366.47 Thousand |
| Earnings Per Share Basic | - | - | -0.00 | -0.00 | - | -0.00 |
| Earnings Per Share Diluted | - | - | -0.00 | -0.00 | - | -0.00 |
| Weighted Average Shares Outstanding | - | - | 143.54 Million | 143.54 Million | 143.54 Million | 143.54 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | 143.54 Million | 143.54 Million | 143.54 Million | 143.54 Million |
| Gross Margin | - | - | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | - | -15.89 | -16.09 | - | -14.82 |
| Profit Margin | - | - | -28.44 | -20.37 | -22.50 | -19.10 |
| EBITDA | - | - | -304.9 Thousand | -308.82 Thousand | - | -284.42 Thousand |
| Earnings Before Tax Margin | - | - | -15.89 | -16.09 | -18.26 | -14.82 |
3324
UTZ
2866
BIGBLOC
FESTI
PZAKY